BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bertrand J, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Powell J. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol. 2011;28:649-654. [PMID: 21995756 DOI: 10.1111/j.1525-1470.2011.01551.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Nieuwenhuis K, de Laat PCJ, Janmohamed SR, Madern GC, Oranje AP. Infantile Hemangioma: Treatment with Short Course Systemic Corticosteroid Therapy as an Alternative for Propranolol: Infantile Hemangioma: Treatment with Short Course Systemic Corticosteroid Therapy. Pediatric Dermatology 2013;30:64-70. [DOI: 10.1111/j.1525-1470.2012.01846.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
2 Marqueling AL, Oza V, Frieden IJ, Puttgen KB. Propranolol and Infantile Hemangiomas Four Years Later: A Systematic Review. Pediatr Dermatol 2013;30:182-91. [DOI: 10.1111/pde.12089] [Cited by in Crossref: 151] [Cited by in F6Publishing: 117] [Article Influence: 16.8] [Reference Citation Analysis]
3 Özyörük D, Zengin E. Propranolol Treatment of Complicated Hemangiomas. Indian J Pediatr 2014;81:368-70. [DOI: 10.1007/s12098-013-1125-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Gupta D, Sidbury R. Cutaneous Congenital Defects. Avery's Diseases of the Newborn. Elsevier; 2018. pp. 1511-1535.e4. [DOI: 10.1016/b978-0-323-40139-5.00107-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Hassan BA, Shreef KS. Propranolol in treatment of huge and complicated infantile hemangiomas in egyptian children. Dermatol Res Pract 2014;2014:541810. [PMID: 24899888 DOI: 10.1155/2014/541810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Gemmete JJ, Pandey AS, Kasten SJ, Chaudhary N. Endovascular Methods for the Treatment of Vascular Anomalies. Neuroimaging Clinics of North America 2013;23:703-28. [DOI: 10.1016/j.nic.2013.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
7 Fette A. Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy. ScientificWorldJournal 2013;2013:850193. [PMID: 23766715 DOI: 10.1155/2013/850193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
8 Rujkijyanont P, Traivaree C, Satayasoontorn K, Photia A, Lertvivatpong N, Monsereenusorn C. Clinical Characteristics and Prognostic Factors in Pediatric Vascular Tumors. Pediatric Health Med Ther 2021;12:43-53. [PMID: 33623471 DOI: 10.2147/PHMT.S297555] [Reference Citation Analysis]
9 Hogeling M. Propranolol for Infantile Hemangiomas: A Review. Curr Derm Rep 2012;1:179-85. [DOI: 10.1007/s13671-012-0026-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Khan IS, Kiehna EN, Satti KF, Ehtesham M, Ghiassi M, Singer RJ. Surgical management of large scalp infantile hemangiomas. Surg Neurol Int 2014;5:41. [PMID: 24818048 DOI: 10.4103/2152-7806.129560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Ishida J, Konishi M, Ebner N, Springer J. Repurposing of approved cardiovascular drugs. J Transl Med 2016;14:269. [PMID: 27646033 DOI: 10.1186/s12967-016-1031-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
12 Menapace D, Mitkov M, Towbin R, Hogeling M. The changing face of complicated infantile hemangioma treatment. Pediatr Radiol 2016;46:1494-506. [PMID: 27450406 DOI: 10.1007/s00247-016-3643-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
13 Park YW, Yeom KB, Choi JW, Kim DY, Shin H, Kim KH. Effect of propranolol on the treatment of infantile hemangiomas: a single tertiary center 3-year experience. J Dermatolog Treat 2014;25:391-5. [PMID: 23273264 DOI: 10.3109/09546634.2012.761667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Anjum MZ, Pasha KH, Abbas SH, Zubair M. The outcome of combination of low dose oral prednisolone with propranolol for the treatment of infantile haemangioma. Pak J Med Sci 2016;32:211-4. [PMID: 27022377 DOI: 10.12669/pjms.321.6390] [Reference Citation Analysis]
15 Gnarra M, Behr G, Kitajewski A, Wu JK, Anupindi SA, Shawber CJ, Zavras N, Schizas D, Salakos C, Economopoulos KP. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5(3): 273-280 [PMID: 27610342 DOI: 10.5409/wjcp.v5.i3.273] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
16 Kaya H, Gokce IK, Gungor S, Turgut H, Ozdemir R. A Newborn with Gastric Hemangioma Treated Using Propranolol. Pediatr Gastroenterol Hepatol Nutr. 2018;21:341-346. [PMID: 30345249 DOI: 10.5223/pghn.2018.21.4.341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Fernandez-Pineda I, Williams R, Ortega-Laureano L, Jones R. Cardiovascular drugs in the treatment of infantile hemangioma. World J Cardiol 2016; 8(1): 74-80 [PMID: 26839658 DOI: 10.4330/wjc.v8.i1.74] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
18 Huoh KC, Rosbe KW. Infantile Hemangiomas of the Head and Neck. Pediatric Clinics of North America 2013;60:937-49. [DOI: 10.1016/j.pcl.2013.04.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
19 Xu P, Yu Q, Huang H, Zhang W, Li W. Lip Infantile Hemangiomas Involving the Vermillion Border Have Worse Outcomes and Prognosis to Oral Propranolol Than Lesions Confined to One Side of the Vermillion. J Oral Maxillofac Surg 2020;78:446-54. [PMID: 31628904 DOI: 10.1016/j.joms.2019.09.010] [Reference Citation Analysis]
20 Huang J, Jiang D, Zhao S, Wang A. Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expression. Anticancer Drugs 2019;30:501-7. [PMID: 30986805 DOI: 10.1097/CAD.0000000000000762] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Léauté-Labrèze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, Ezzedine K, Moore N. Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants & lt; 4 months of age. Br J Dermatol. 2013;169:181-183. [PMID: 23301692 DOI: 10.1111/bjd.12217] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
22 Spence-Shishido AA, Good WV, Baselga E, Frieden IJ. Hemangiomas and the eye. Clin Dermatol 2015;33:170-82. [PMID: 25704937 DOI: 10.1016/j.clindermatol.2014.10.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
23 Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol 2013;14:111-23. [PMID: 23338947 DOI: 10.1007/s40257-013-0008-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
24 Marey HM, Elmazar HF, Mandour SS, Khairy HA. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma. J Pediatr Ophthalmol Strabismus 2018;55:37-42. [DOI: 10.3928/01913913-20170703-12] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
25 You Y, Li Y, Xiao Y, Zhang J. Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta-analysis. Mol Clin Oncol 2021;15:156. [PMID: 34178327 DOI: 10.3892/mco.2021.2318] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Bouchard C, Peacock ZS, Troulis MJ. Pediatric Vascular Tumors of the Head and Neck. Oral Maxillofac Surg Clin North Am 2016;28:105-13. [PMID: 26293330 DOI: 10.1016/j.coms.2015.07.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Liang MG, Frieden IJ. Infantile and congenital hemangiomas. Semin Pediatr Surg. 2014;23:162-167. [PMID: 25241092 DOI: 10.1053/j.sempedsurg.2014.06.017] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 7.1] [Reference Citation Analysis]
28 Lou Y, Peng WJ, Cao Y, Cao DS, Xie J, Li HH. The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol. 2014;78:44-57. [PMID: 24033819 DOI: 10.1111/bcp.12235] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
29 Izadpanah A, Izadpanah A, Kanevsky J, Belzile E, Schwarz K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg. 2013;131:601-613. [PMID: 23142941 DOI: 10.1097/prs.0b013e31827c6fab] [Cited by in Crossref: 68] [Cited by in F6Publishing: 22] [Article Influence: 7.6] [Reference Citation Analysis]
30 Panditray S, Acharya S, Prusty N, Dany SS. Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate. Indian J Otolaryngol Head Neck Surg 2019;71:566-73. [PMID: 31742022 DOI: 10.1007/s12070-018-1410-8] [Reference Citation Analysis]
31 Kaneko T, Sasaki S, Baba N, Koh K, Matsui K, Ohjimi H, Hayashi N, Nakano A, Ohki K, Kuwano Y, Morimoto A, Tamaki Z, Kakazu M, Kishi K, Oyama T, Sato A, Kato R, Higuchi T. Efficacy and safety of oral propranolol for infantile hemangioma in Japan. Pediatrics International 2017;59:869-77. [DOI: 10.1111/ped.13318] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
32 Kim KH, Choi TH, Choi Y, Park YW, Hong KY, Kim DY, Choe YS, Lee H, Cheon JE, Park JB, Park KD, Kang HJ, Shin HY, Jeong JH. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial. JAMA Dermatol 2017;153:529-36. [PMID: 28423174 DOI: 10.1001/jamadermatol.2017.0250] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
33 Hoornweg MJ, Saeed P, Tanck MW, Hage JJ, Coumou AD, Van Der Horst CM. Comparison of intralesional corticosteroid and propranolol treatment of periorbital infantile hemangiomas: an outcome study of 61 cases. Eur J Ophthalmol 2014;24:940-7. [PMID: 24729139 DOI: 10.5301/ejo.5000467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
34 Gunturi N, Ramgopal S, Balagopal S, Scott JX. Propranolol therapy for infantile hemangioma. Indian Pediatr 2013;50:307-13. [PMID: 23680605 DOI: 10.1007/s13312-013-0098-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
35 Rialon KL, Murillo R, Fevurly RD, Kulungowski AM, Christison-Lagay ER, Zurakowski D, Kozakewich HP, Alomari AI, Fishman SJ. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg. 2015;50:837-841. [PMID: 25783331 DOI: 10.1016/j.jpedsurg.2014.09.056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
36 Xu SQ, Jia RB, Zhang W, Zhu H, Ge SF, Fan XQ. Beta-blockers versus corticosteroids in the treatment of infantile hemangioma: an evidence-based systematic review. World J Pediatr. 2013;9:221-229. [PMID: 23929254 DOI: 10.1007/s12519-013-0427-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
37 Zhao J, Huang AH, Rainer BM, Kryatova MS, Eghrari AO, Wang J, Puttgen KB, Cohen BA. Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes. Pediatr Dermatol 2019;36:830-4. [PMID: 31448460 DOI: 10.1111/pde.13925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
38 Aljebab F, Choonara I, Conroy S. Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children. PLoS One 2017;12:e0170259. [PMID: 28125632 DOI: 10.1371/journal.pone.0170259] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
39 Hu L, Zhou B, Huang H, Chang L, Qiu Y, Ma G, Chen H, Jin Y, Xu X, Lin X, Li W. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas. J Dermatol 2016;43:1160-6. [PMID: 26945921 DOI: 10.1111/1346-8138.13324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
40 Sethuraman G, Yenamandra VK, Gupta V. Management of infantile hemangiomas: current trends. J Cutan Aesthet Surg 2014;7:75-85. [PMID: 25136206 DOI: 10.4103/0974-2077.138324] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
41 Soukoulis IW, Liang MG, Fox VL, Mulliken JB, Alomari AI, Fishman SJ. Gastrointestinal Infantile Hemangioma: Presentation and Management. J Pediatr Gastroenterol Nutr 2015;61:415-20. [PMID: 25859824 DOI: 10.1097/MPG.0000000000000812] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]